Skip to main content
Erschienen in: Rheumatology International 5/2012

01.05.2012 | Original Article

Comparison of serological markers between ACPA+ and ACPA of RA patients

verfasst von: Chunhua Xun, Yong Zhao

Erschienen in: Rheumatology International | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Anti-citrullinated protein/peptide antibodies (ACPA) have recently emerged as sensitive and specific serological markers of rheumatoid arthritis (RA), providing superior alternative of the rheumatoid factor (RF) test in the laboratory diagnostics of RA. We compare the change of serum RF, CRP, IgG, IgM, IgA, total complement, C3 and C4. The sera sample was collected from 123 patients with RA. ACPA were detected with ELISA, and RF, CRP and total complement (Ct), C3 and C4 were examined by automatic biochemical analyzer. Serum RF and total complement concentrations were significantly higher in ACPA+ than in ACPA−, but there were no correlation between ACPA and RF and Ct. Between ACPA+ and ACPA−, there were no significant difference of CRP, IgG, IgM, IgA, total complement, C3 and C4. While there were significant correlation between the concentration of C3 and IgM and ACPA in ACPA+. Conclusion: This is the first study to show that ACPA concentration in ACPA+ patients with RA is positively related to serum IgM and C3 levels.
Literatur
1.
Zurück zum Zitat Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4(suppl 2):S1–S5PubMedCrossRef Steiner G, Smolen J (2002) Autoantibodies in rheumatoid arthritis and their clinical significance. Arthritis Res 4(suppl 2):S1–S5PubMedCrossRef
2.
Zurück zum Zitat Van Boekel MAM, Vossenaar E, van den Hoogen FHJ, van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4:87–93PubMedCrossRef Van Boekel MAM, Vossenaar E, van den Hoogen FHJ, van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4:87–93PubMedCrossRef
3.
Zurück zum Zitat Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155–163PubMedCrossRef Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, van Venrooij WJ (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155–163PubMedCrossRef
4.
Zurück zum Zitat Conrad K, Roggenbuck D, Reinhold D et al (2010) Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 9:431–435PubMedCrossRef Conrad K, Roggenbuck D, Reinhold D et al (2010) Profiling of rheumatoid arthritis associated autoantibodies. Autoimmun Rev 9:431–435PubMedCrossRef
5.
Zurück zum Zitat Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324PubMedCrossRef
6.
Zurück zum Zitat Egeland T, Munthe E (1983) The role of the laboratory in rheumatology. Rheumatoid factors. Clin Rheum Dis 9:135–160PubMed Egeland T, Munthe E (1983) The role of the laboratory in rheumatology. Rheumatoid factors. Clin Rheum Dis 9:135–160PubMed
7.
Zurück zum Zitat Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273–281PubMedCrossRef Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, van Venrooij WJ (1998) Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101:273–281PubMedCrossRef
8.
Zurück zum Zitat Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155–163PubMedCrossRef Schellekens GA, Visser H, de Jong BA et al (2000) The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43:155–163PubMedCrossRef
9.
Zurück zum Zitat Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365PubMedCrossRef Visser H, le Cessie S, Vos K, Breedveld FC, Hazes JM (2002) How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 46:357–365PubMedCrossRef
10.
Zurück zum Zitat Suzuki K, Sawada T, Murakami A et al (2003) High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32:197–204PubMedCrossRef Suzuki K, Sawada T, Murakami A et al (2003) High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 32:197–204PubMedCrossRef
11.
Zurück zum Zitat van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4:87–93PubMedCrossRef van Boekel MA, Vossenaar ER, van den Hoogen FH, van Venrooij WJ (2002) Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 4:87–93PubMedCrossRef
12.
Zurück zum Zitat van Venrooij WJ, Hazes JM, Visser H (2002) Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 60:383–388PubMed van Venrooij WJ, Hazes JM, Visser H (2002) Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis. Neth J Med 60:383–388PubMed
13.
Zurück zum Zitat Vasishta A (2002) Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab 21:34–36PubMed Vasishta A (2002) Diagnosing early-onset rheumatoid arthritis: the role of anti-CCP antibodies. Am Clin Lab 21:34–36PubMed
14.
Zurück zum Zitat JansenAL, van derHorst-Bruinsma I, van SchaardenburgD, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29:2074–6 JansenAL, van derHorst-Bruinsma I, van SchaardenburgD, van de Stadt RJ, de Koning MH, Dijkmans BA (2002) Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 29:2074–6
15.
Zurück zum Zitat Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079–1084PubMedCrossRef Vallbracht I, Rieber J, Oppermann M, Forger F, Siebert U, Helmke K (2004) Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis. Ann Rheum Dis 63:1079–1084PubMedCrossRef
16.
Zurück zum Zitat Péter Szodoray, Zoltán Szabó, Anikó Kapitány et al. (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis[J]. Autoimmun Rev 9:140–143 Péter Szodoray, Zoltán Szabó, Anikó Kapitány et al. (2010) Anti-citrullinated protein/peptide autoantibodies in association with genetic and environmental factors as indicators of disease outcome in rheumatoid arthritis[J]. Autoimmun Rev 9:140–143
17.
Zurück zum Zitat Song YW, Kang EH (2010) Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies[J]. Q J Med 103:139–146 Song YW, Kang EH (2010) Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies[J]. Q J Med 103:139–146
18.
Zurück zum Zitat Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M et al (2008) Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 58:678–688PubMedCrossRef Clavel C, Nogueira L, Laurent L, Iobagiu C, Vincent C, Sebbag M et al (2008) Induction of macrophage secretion of tumor necrosis factor α through Fcγ receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 58:678–688PubMedCrossRef
19.
Zurück zum Zitat Hiromi Kubagawa, Satoshi Oka, Yoshiki Kubagawa, et al. (2009) Identity of the elusive IgM Fc receptor(FcμR) in humans. J. Exp. Med 206 (12): 2779–2793 Hiromi Kubagawa, Satoshi Oka, Yoshiki Kubagawa, et al. (2009) Identity of the elusive IgM Fc receptor(FcμR) in humans. J. Exp. Med 206 (12): 2779–2793
20.
Zurück zum Zitat Sjoberg AP, Trouw LA, Blom AM (2009) Complement activation and inhibition: a delicate balance. Trends Immunol 30:83–90PubMedCrossRef Sjoberg AP, Trouw LA, Blom AM (2009) Complement activation and inhibition: a delicate balance. Trends Immunol 30:83–90PubMedCrossRef
21.
Zurück zum Zitat Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M et al (2002) Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 46:934–945PubMedCrossRef Neumann E, Barnum SR, Tarner IH, Echols J, Fleck M, Judex M et al (2002) Local production of complement proteins in rheumatoid arthritis synovium. Arthritis Rheum 46:934–945PubMedCrossRef
22.
Zurück zum Zitat Swaak AJ, van Rooyen A, Planten O, Han H, Hattink O, Hack E (1987) An analysis of the levels of complement components in the synovial fluid in rheumatic diseases. Clin Rheumatol 6:350–357PubMedCrossRef Swaak AJ, van Rooyen A, Planten O, Han H, Hattink O, Hack E (1987) An analysis of the levels of complement components in the synovial fluid in rheumatic diseases. Clin Rheumatol 6:350–357PubMedCrossRef
23.
Zurück zum Zitat Brodeur JP, Ruddy S, Schwartz LB, Moxley G (1991) Synovial fluid levels of complement SC5b–9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 34:1531–1537PubMedCrossRef Brodeur JP, Ruddy S, Schwartz LB, Moxley G (1991) Synovial fluid levels of complement SC5b–9 and fragment Bb are elevated in patients with rheumatoid arthritis. Arthritis Rheum 34:1531–1537PubMedCrossRef
24.
Zurück zum Zitat Engelmann R, Brandt J, Eggert M, Karberg K, Krause A, Neeck G et al (2008) IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA. Rheumatology (Oxford) 47:1489–1492CrossRef Engelmann R, Brandt J, Eggert M, Karberg K, Krause A, Neeck G et al (2008) IgG1 and IgG4 are the predominant subclasses among auto-antibodies against two citrullinated antigens in RA. Rheumatology (Oxford) 47:1489–1492CrossRef
25.
Zurück zum Zitat Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ et al (2006) Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 54:3799–3808PubMedCrossRef Verpoort KN, Jol-van der Zijde CM, Papendrecht-van der Voort EA, Ioan-Facsinay A, Drijfhout JW, van Tol MJ et al (2006) Isotype distribution of anti-cyclic citrullinated peptide antibodies in undifferentiated arthritis and rheumatoid arthritis reflects an ongoing immune response. Arthritis Rheum 54:3799–3808PubMedCrossRef
26.
Zurück zum Zitat Trouw LA, Haisma EM, Levarht EWN et al. (2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways[J]. Arthritis Rheum 60(7):1923–1931 Trouw LA, Haisma EM, Levarht EWN et al. (2009) Anti-cyclic citrullinated peptide antibodies from rheumatoid arthritis patients activate complement via both the classical and alternative pathways[J]. Arthritis Rheum 60(7):1923–1931
Metadaten
Titel
Comparison of serological markers between ACPA+ and ACPA− of RA patients
verfasst von
Chunhua Xun
Yong Zhao
Publikationsdatum
01.05.2012
Verlag
Springer-Verlag
Erschienen in
Rheumatology International / Ausgabe 5/2012
Print ISSN: 0172-8172
Elektronische ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1757-y

Weitere Artikel der Ausgabe 5/2012

Rheumatology International 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.